Long‐term maintenance treatment of gastric ulcers with ranitidine

Authors:

Abstract
SUMMARY: One hundred and twenty patients with gastric ulcer disease, who had been receiving maintenance treatment with ranitidine (150 or 300 mg/day) for periods up to 7 years, were studied retrospectively. The proportion of patients remaining free from symptomatic recurrence of ulcer during maintenance treatment was 97% after 1 year; 90% after 3 years; and 79% after 5 years. No patient developed haemorrhage or perforation during maintenance treatment. None of the demographic features was shown to be associated with a significantly increased risk of ulcer recurrence during maintenance treatment.Comparison of the recurrence rates during maintenance treatment with those during periods without active anti‐ulcer therapy, using life table and incidence density analysis, showed a significant difference in favour of maintenance treatment.We conclude that maintenance treatment with ranitidine for 5 years significantly reduces the risk of symptomatic ulcer recurrence in patients with gastric ulcer.

This publication has 22 references indexed in Scilit: